News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
317 Results
Type
Article (15)
Press Release (302)
Section
Business (66)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
Best Places to Work (40)
Brain cancer (3)
Cancer (9)
Clinical research (71)
Collaboration (1)
COVID-19 (5)
Data (11)
Diagnostics (5)
Earnings (33)
Events (77)
FDA (14)
Funding (1)
Government (6)
Healthcare (6)
Infectious disease (5)
Intellectual property (2)
IPO (11)
Job creations (1)
Liver cancer (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2026 (6)
Non-profit (1)
Pancreatic cancer (4)
Patents (4)
Patient recruitment (1)
People (16)
Phase 1 (50)
Phase 2 (39)
Phase 3 (18)
Pipeline (6)
Preclinical (19)
Real estate (1)
Regulatory (16)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (36)
2026 (3)
2025 (33)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (1)
Canada (1)
Europe (3)
Texas (37)
United States (37)
317 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
February 5, 2026
·
3 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
·
6 min read
Press Releases
Moleculin Announces New Annamycin Collaboration in Brain Tumors
December 8, 2025
·
6 min read
Press Releases
Moleculin to Participate in the Virtual Investor Closing Bell Series
November 27, 2025
·
2 min read
Press Releases
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
December 11, 2025
·
5 min read
Press Releases
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
January 13, 2026
·
10 min read
Press Releases
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
October 30, 2025
·
5 min read
Press Releases
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
December 10, 2025
·
7 min read
Press Releases
Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors
December 18, 2025
·
7 min read
Press Releases
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
October 24, 2025
·
8 min read
1 of 32
Next
